Ignite Creation Date:
2025-12-25 @ 4:14 AM
Ignite Modification Date:
2026-02-22 @ 4:10 AM
Study NCT ID:
NCT03747120
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-06-27
First Post:
2018-11-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab [IIT2018-04-MCARTHUR-NEOHP]
Sponsor:
University of Texas Southwestern Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-01-25
Start Date Type:
ACTUAL
Primary Completion Date:
2024-11-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2029-12
Completion Date Type:
ESTIMATED
First Submit Date:
2018-11-16
First Submit QC Date:
None
Study First Post Date:
2018-11-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-03-27
Results First Submit QC Date:
None
Results First Post Date:
2025-05-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-10
Last Update Post Date:
2025-06-27
Last Update Post Date Type:
ACTUAL